Cresco Labs: Analyst Q4 2020 Consensus Expectations

Cresco Labs (CSE: CL) announced that they will be reporting their fourth quarter and year-end financials pre-market on March 25th. Analysts have a consensus C$22.22 12-month price target on the company, via a total of 16 analysts, with four analysts having a strong buy rating and the other 11 have buy ratings and one analyst has a hold rating. The street high comes from Stifel-GMP with a C$36 price target, and the lowest target comes from Roth Capital with a C$17.50 price target.

Sixteen analysts have revenue estimates for the fourth quarter. The mean between all 16 is U$161.38 million; this number has been revised downwards from U$162.50 million at the start of the year. Needham & Co currently has the highest revenue estimate with U$167.8 million, while the lowest comes from Piper Sandler with a U$156.1 million estimate.

For the full year, the average revenue estimate between 16 analysts is currently U$475.52 million. This number has been revised downwards from U$475.52 million at the start of the year. The street high comes from Needham & Co with a U$481.70 full-year revenue estimate, while the lowest comes from Piper Sandler with a U$470 million estimate.

Onto EBITDA estimates, there are currently 14 analysts who have fourth-quarter EBITDA estimates. The mean is currently U$48.06 million, with this number roughly the same since the start of the year. Street high goes to Needham & Co with a U$52,14 million EBITDA estimate and the lowest being ATB Capital with a U$42.20 million estimate.

For the full year, the current EBITDA mean across 12 analysts is U$114.13 million. This number is roughly the same since the start of the year. Needham & Co currently has the highest full-year estimate at U$118.21 million and the lowest being Benchmark with a U$158 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

First Majestic Aims To Restart Production At Jerritt Canyon In H2 2027

Mercado Minerals Identifies A Series Of New Targets Following LiDAR Survey At Copalito

Related News

Kinross: BMO Views Revised Russian Asset Sale As Positive, Despite Halving Of Sales Figure

On June 15th, Kinross Gold Corporation (TSX: K) announced that it had completed its sale...

Saturday, June 18, 2022, 03:12:00 PM

Cresco Labs Purchases Origin House With Tiny Premium Becoming One of the Largest MSOs

Today Cresco Labs announced they are acquiring Origin House for C$1.1B which works out to...

Monday, April 1, 2019, 01:37:11 PM

Canaccord: Virgin Galactic Selloff Is Overdone

Virgin Galactic Holdings (NYSE: SPCE) over the weekend had their first successful launch into suborbital...

Tuesday, July 13, 2021, 12:51:00 PM

Lyft: Analysts Expect Consensus $556.4 Million In Q1 Revenues

Lyft Inc (NASDAQ: LYFT) will be reporting its first quarter financial results today after market...

Tuesday, May 4, 2021, 02:31:00 PM

Verano: Canaccord Reiterates Ratings Following Pennsylvania Purchases

On April 22nd, Verano Holdings (CSE: VRNO) announced that they acquired two cultivation licenses in...

Saturday, April 24, 2021, 01:25:00 PM